Results 271 to 280 of about 129,288 (306)

Multimodal AI-based risk stratification for distant metastasis in nasopharyngeal carcinoma. [PDF]

ESMO Open
Zhou J, Wibawa MS, Wang R, Deng Y, Huang H, Luo Z, Xia Y, Guo X, Young LS, Lo KW, Rajpoot N, Lv X.   +11 more
europepmc   +1 more source

Hormonal and reproductive factors and risk of nasopharyngeal carcinoma in Chinese women: a case-control study. [PDF]

BMC Res Notes
Su XY, Schroder A, Tse LA, Yu IT, Xie SH.   +4 more
europepmc   +1 more source

Autophagy inhibition in LGALS9-overexpressing nasopharyngeal carcinoma unleashes immune response. [PDF]

Autophagy
Pascual C, Klionsky DJ, Klionsky DJ.
europepmc   +1 more source

YTHDF2 enhances proliferation and metastasis of nasopharyngeal carcinoma by mediating m6A modification in destabilizing FOXO1 mRNA. [PDF]

Cancer Biol Ther
Yu P, Wei W, Peng X, Ye J, Ji Y, Zhang B, Cai Y.   +6 more
europepmc   +1 more source

Prognostic Significance of Cervical Lymph Node Biopsy in Nasopharyngeal Carcinoma Patients: A Retrospective Analysis. [PDF]

Cancer Manag Res
Sang R, Tang Z, Xu X, Qin S, Zhou J.
europepmc   +1 more source

Adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: where do we stand? [PDF]

BMJ Oncol
Yip PL, Lee SF, Chua M.
europepmc   +1 more source

Overexpression of STOML1 is associated with good prognosis in nasopharyngeal carcinoma. [PDF]

Oncol Lett
Liu HT, Li M, Qu SH, Cheng JJ, Liang P, Lu JL, Deng S, Gu JZ, Luo YQ, Gui Z, Huang WL, Chen JX.   +11 more
europepmc   +1 more source

Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma? [PDF]

BMC Cancer
Guo LF, Yu YF, Lu ZZ, Lin Q, Wu SG.
europepmc   +1 more source